ArticleJournal of clinical medicine2026

Exploring Radiographic Progression-Free Survival in Diverse Subgroups of Metastatic Hormone-Sensitive Prostate Cancer: Comparative Efficacy of Abiraterone and Enzalutamide.

Aykut Özmen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.